|
|
|
|
|
|
|
Educação Continuada - Artigos em destaque - Câncer de Pulmão |
-
Autores dos comentários: Dr. Mauro Zukin, Dr. Rodrigo Dienstmann, Dr. Luiz Henrique Araujo
Efficacy and side effects of cisplatin and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials
Rajeswaran A, Trojan A, Burnand B, Giannelli M
Lung Cancer. 2008;59(1):1-11
-
Autores dos comentários: Dr. Mauro Zukin, Dr. Rodrigo Dienstmann, Dr. Luiz Henrique Araujo
Outcomes of Adrenalectomy for Isolated Synchronous versus Metachronous Adrenal Metastases in Non–Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis.
Tanvetyanon T, Robinson LA, Schell MJ, Strong VE, Kapoor R, Coit DG, Bepler G
J Clin Oncol. 2008;26(7):1142-7
-
Autores dos comentários: Dr. Mauro Zukin, Dr. Rodrigo Dienstmann, Dr. Luiz Henrique Araujo
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non small-cell lung cancer.
Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, Lee JS, Mellemgaard A, Park K, Patil S, Rolski J, Goksel T, de Marinis F, Simms L, Sugarman KP, Gandara D
J Clin Oncol. 2008; 26(21): 3543-51
-
Autores dos comentários: Dr. Mauro Zukin, Dr. Rodrigo Dienstmann, Dr. Luiz Henrique Araujo
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and US Oncology.
Hanna N, Neubauer M, Yiannoutsos C, McGarry R, Arseneau J, Ansari R, Reynolds C, Govindan R, Melnyk A, Fisher W, Richards D, Bruetman D, Anderson T, Chowhan N, Nattam S, Mantravadi P, Johnson C, White A, Einhorn L
J Clin Oncol. 2008; 26(35): 5755-60
-
Autores dos comentários: Dr. Mauro Zukin, Dr. Rodrigo Dienstmann, Dr. Luiz Henrique Araujo
Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.
Smit EF, Burgers SA, Biesma B, Smit HJ, Eppinga P, Dingemans AM, Joerger M, Schellens JH, Vincent A, van Zandwijk N, Groen HJ
J Clin Oncol. 2009;27:2038-45
-
Autores dos comentários: Dr. Mauro Zukin, Dr. Rodrigo Dienstmann, Dr. Luiz Henrique Araujo
Phase III study of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.
Reck M, von Pawel M, Zatloukal P, Ramlau R, Gorbounova V, Hirsh V, Leighl N, Mezger J, Archer V, Moore N, Manegold C
J Clin Oncol. 2009;27:1227-1234
-
Autores dos comentários: Dr. Mauro Zukin, Dr. Rodrigo Dienstmann, Dr. Luiz Henrique Araujo
Adjuvant paclitaxel plus carboplatin compared with observation in stage ib non-small-cell lung cancer: calgb 9633 with the cancer and leukemia group b, radiation therapy oncology group, and north central cancer treatment group study groups.
Strauss GM, Herndon JE, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR
J Clin Oncol. 2008;26(31):5043-5051
-
Autores dos comentários: Dr. Mauro Zukin, Dr. Rodrigo Dienstmann, Dr. Luiz Henrique Araujo
Duration of chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials.
Soon YY, Stockler MR, Askie LM, Boyer MJ
J Clin Oncol. 2009;27(20):3277-3283
|
|
|
|
|
|
